Stock market week-in-review for 5 large GI companies — Nov. 20-24

Here is how five major, publicly traded gastroenterology companies fared in the stock market for the week of Nov. 20 to Nov. 24, 2017.

Advertisement

Note: This data was compiled using Google Finance.

1. Allergan Pharmaceuticals

Opened: $174.92 on Nov. 20
Peaked: $176 on Nov. 22
Closed: $173.59 on Nov. 24
Percent change between Nov. 20 and Nov. 24: -0.76 percent

2. Exact Sciences Corp.

Opened: $58.87 on Nov. 20
Peaked: $59.97 on Nov. 21
Closed: $59.27 on Nov. 24
Percent change between Nov. 20 and Nov. 24: 0.67 percent

3. Johnson & Johnson

Opened: $137.98 on Nov. 20
Peaked: $139.24 on Nov. 21
Closed: $138.04 on Nov. 24
Percent change between Nov. 20 and Nov. 24: 0.04 percent

4. Synergy Pharmaceuticals

Opened: $1.95 on Nov. 20
Peaked at open
Closed: $1.90 on Nov. 24
Percent change between Nov. 20 and Nov. 24: -2.56 percent

5. Valeant Pharmaceuticals

Opened: $14.69 on Nov. 20
Peaked: $16.83 on Nov. 22
Closed: $16.56 on Nov. 24
Percent change between Nov. 20 and Nov. 24: 12.72 percent

More articles on gastroenterology: 
Preventable factors raise cancer risk in the US — 5 insights
SGS withdraws GI Dynamics’ CE Mark & more — 6 GI company key notes
IQuilty introduces RNA-based blood test for IBS, IBD — 3 insights 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Building a High-Performance Cardiac PET Program: What Health Systems Should Consider

Thursday, July 30
12:00 PM - 1:00 PM CDT

Presenters: Rupa Sanghani, MD, FACC, FASNC, Rush University Medical CenterBrendon Loiselle, CDL Nuclear Technologies

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.